PF-07899895

N/A

Report date: 2024/06/21 16:38:42

Base Information

Drug NamePF-07899895

Drug Alias NamePF-07899895

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSalt-inducible kinases inhibitors

TargetsSalt-inducible kinases

Therapy Area/IndicationsColitis, Ulcerative

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsColitis, Ulcerative

Inactive IndicationsN/A

ATC CodeN/A